down arrow

Sun Pharma.Inds.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,692.15
40.15 (2.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 24.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Dec'23
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
25,944.14
36,513.95
24,133.25
21,714.04
19,344.67
16,138.38
16,497.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
25,944.14
36,513.95
24,133.25
21,714.04
19,344.67
16,138.38
16,497.71
Raw Material Cost
3,195.73
5,227.60
3,517.94
4,017.94
3,147.04
2,978.72
2,809.88
Purchase of Finished goods
1,872.53
2,483.27
1,686.78
1,791.88
1,836.72
1,565.01
1,661.36
(Increase) / Decrease In Stocks
301.37
571.33
340.54
-201.55
187.53
-427.80
254.41
Employee Cost
4,932.32
7,129.72
4,766.40
4,079.41
3,565.01
3,464.33
3,161.34
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
1,008.20
0.00
0.00
0.00
Other Expenses
8,095.61
11,114.05
7,310.44
5,177.22
5,157.35
4,521.33
4,825.37
Total Expenditure (Excl Depreciation)
18,397.56
26,525.97
17,622.10
15,873.10
13,893.65
12,101.59
12,712.36
Operating Profit (PBDIT) excl Other Income
7,546.58
9,987.98
6,511.15
5,840.94
5,451.02
4,036.79
3,785.35
Other Income
886.55
748.25
498.05
87.36
375.41
409.57
413.87
Operating Profit (PBDIT)
8,433.13
10,736.23
7,009.20
5,928.30
5,826.43
4,446.36
4,199.22
Interest
130.71
164.90
130.17
33.08
71.04
85.23
187.99
Exceptional Items
0.00
-392.68
-322.87
0.00
-631.07
-3,633.33
0.00
Gross Profit (PBDT)
8,302.42
10,178.65
6,556.16
5,895.22
5,124.32
727.80
4,011.23
Depreciation
1,281.04
1,906.28
1,284.14
1,197.95
1,033.59
994.52
930.41
Profit Before Tax
7,021.38
8,272.37
5,272.02
4,697.27
4,090.73
-266.72
3,080.82
Tax
1,119.46
1,290.52
858.20
341.25
593.35
214.71
412.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,901.92
6,981.85
4,413.82
4,356.02
3,497.38
-481.43
2,668.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,901.92
6,981.85
4,413.82
4,356.02
3,497.38
-481.43
2,668.73
Share in Profit of Associates
-4.08
-30.56
-23.07
-6.73
-7.00
-2.04
-8.91
Minority Interest
-22.06
-29.49
7.30
-26.19
0.80
640.66
-208.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,875.78
6,921.80
4,398.05
4,323.10
3,491.18
157.19
2,451.57
Equity Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
68,874.97
0.00
0.00
0.00
49,296.32
0.00
0.00
Earnings per share (EPS)
24.49
28.85
18.33
18.02
14.55
0.66
10.22
Diluted Earnings per share
24.5
28.8
18.3
18.0
14.5
0.66
10.22
Operating Profit Margin (Excl OI)
29.26%
27.79%
27.37%
27.23%
28.35%
25.35%
23.35%
Gross Profit Margin
32.19%
28.32%
27.56%
27.48%
26.65%
4.57%
24.75%
PAT Margin
22.89%
19.42%
18.55%
20.3%
18.19%
-3.02%
16.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 7.50%

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 33.60%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 15.90%

stock-summary

Interest

Growth in half year ended Sep 2024 is 0.41%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has improved from Sep 2023

Compare Half Yearly Results Of Sun Pharma.Inds. With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
25,944.14
4,456.00
21,488.14
482.23%
Other Operating Income
0.00
0.00
0.00
Total Operating income
25,944.14
4,456.00
21,488.14
482.23%
Raw Material Cost
3,195.73
1,869.00
1,326.73
70.99%
Purchase of Finished goods
1,872.53
0.00
1,872.53
(Increase) / Decrease In Stocks
301.37
-47.00
348.37
741.21%
Employee Cost
4,932.32
596.00
4,336.32
727.57%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
8,095.61
699.00
7,396.61
1,058.17%
Total Expenditure (Excl Depreciation)
18,397.56
3,117.00
15,280.56
490.23%
Operating Profit (PBDIT) excl Other Income
7,546.58
1,339.00
6,207.58
463.60%
Other Income
886.55
184.00
702.55
381.82%
Operating Profit (PBDIT)
8,433.13
1,523.00
6,910.13
453.72%
Interest
130.71
1.00
129.71
12,971.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
8,302.42
1,522.00
6,780.42
445.49%
Depreciation
1,281.04
196.00
1,085.04
553.59%
Profit Before Tax
7,021.38
1,326.00
5,695.38
429.52%
Tax
1,119.46
386.00
733.46
190.02%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
5,901.92
940.00
4,961.92
527.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
5,901.92
940.00
4,961.92
527.86%
Share in Profit of Associates
-4.08
0.00
-4.08
Minority Interest
-22.06
0.00
-22.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,875.78
940.00
4,935.78
525.08%
Equity Capital
239.93
53.00
186.93
352.70%
Face Value
1.00
2.00
0.00
Reserves
68,874.97
0.00
68,874.97
Earnings per share (EPS)
24.49
35.47
-10.98
-30.96%
Diluted Earnings per share
24.50
35.40
-10.90
-30.79%
Operating Profit Margin (Excl OI)
29.26%
30.05%
0.00
-0.79%
Gross Profit Margin
32.19%
34.16%
0.00
-1.97%
PAT Margin
22.89%
21.10%
0.00
1.79%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 25,944.14 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 7.50%

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 5,875.78 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 33.60%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7,546.58 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 15.90%

Half Yearly - Interest
Interest 130.71 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 0.41%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.26%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has improved from Sep 2023